Oldest pages

Showing below up to 50 results in range #2,301 to #2,350.

Animal bite (16:29, 30 July 2025)
Culture-negative endocarditis (16:29, 30 July 2025)
Skin and soft tissue infections (SSTI) (IDSA 2014) (16:29, 30 July 2025)
Vibrio metschnikovii (14:25, 1 August 2025)
Vibrionaceae (00:43, 2 August 2025)
Vibrio (01:45, 2 August 2025)
Chromobacterium violaceum (01:51, 2 August 2025)
Eikenella corrodens (01:56, 2 August 2025)
Linezolid (21:31, 11 August 2025)
Polatuzumab vedotin (15:46, 18 August 2025)
Fidaxomicin (15:48, 19 August 2025)
CR:DOI:1c9d23338034a184da12d3bfc6764267 (14:51, 20 August 2025)
West Nile virus (16:02, 21 August 2025)
Parkinson-plus syndrome (19:20, 21 August 2025)
Peritoneal carcinomatosis (01:06, 3 September 2025)
Streptococcus gordonii (00:53, 4 September 2025)
Eosinophilic cellulitis (18:13, 8 September 2025)
CR:DOI:cec85d75d06e8681143a9c823fe4b66f (15:03, 9 September 2025)
Corynebacterium striatum (15:06, 9 September 2025)
CR:DOI:7a71a1068c5ec01ab6e0764dcec5f8c2 (15:08, 9 September 2025)
Avacopan (17:51, 9 September 2025)
CR:DOI:166fe0f64e8fdd4b6ae50910a9996d1a (14:57, 11 September 2025)
Recurrent meningitis (15:47, 18 September 2025)
Drug-induced aseptic meningitis (15:50, 18 September 2025)
Headache with neurological deficits and cerebrospinal fluid lymphocytosis (15:53, 18 September 2025)
Diabetic foot ulcer (16:05, 18 September 2025)
WIfI system (16:58, 18 September 2025)
Diabetic foot infection (17:00, 18 September 2025)
CR:DOI:2c78080545901114e8b6601446040655 (03:20, 19 September 2025)
CR:DOI:13a597f6f29e1c215a69fc2351732611 (03:29, 19 September 2025)
Recurrent tuberculosis (03:29, 19 September 2025)
CR:PMID:20074418 (03:30, 19 September 2025)
CR:DOI:5d6fdd1fb4d601ac3b859435236fe3d1 (03:49, 19 September 2025)
CR:DOI:3917348f8490a2874a73be4769774c60 (03:51, 19 September 2025)
CR:DOI:93a20281efae8df25b04c217a2b9e759 (03:54, 19 September 2025)
Tuberculous adenitis (04:01, 19 September 2025)
Central venous access device-related upper extremity deep vein thrombosis (14:11, 19 September 2025)
Granulomatous disease (14:30, 24 September 2025)
Golimumab (18:37, 29 September 2025)
Drug-induced thrombocytopenia (20:46, 29 September 2025)
Prosthetic joint infection (16:15, 30 September 2025)
Kawasaki disease (18:27, 30 September 2025)
Leptospira (18:34, 30 September 2025)
Anaplasma phagocytophilum (19:05, 30 September 2025)
CR:DOI:877d53e0da2abb06283993a9959f1ac8 (14:29, 2 October 2025)
CR:DOI:415d00cc0f165bd9079d5acf07764747 (14:36, 2 October 2025)
CR:DOI:1ec3e49d4680d8d915977fc8bb2ee8c4 (14:58, 2 October 2025)
CR:DOI:484c0725a5f4bd4d826b3f1321b5686d (15:00, 2 October 2025)
CR:DOI:d14017def84fc22da503fdd490bb0b3a (15:02, 2 October 2025)
Enfortumab vedotin (15:32, 2 October 2025)